CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 4. Promoter III Oct-1 binding site function in melanoma cell lines. Melanoma cell lines were transiently transfected with a wild-type promoter III luciferase construct and a promoter III construct with a mutated Oct-1-DNA binding site. After 48 h, cells were harvested for luciferase activity assays. The wild-type luciferase counts were normalized to unity to display relative fold induction for the mutated promoter.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation